• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21721 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2001     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) The birth of a new type of treatment. Cells extracted from other species for use in treating diseases in humans. (Short version of the TA study 'Xenotransplantation of cells')
2015     NIHR Health Services and Delivery Research programme The Birthplace in England national prospective cohort study: further analyses to enhance policy and service delivery decision-making for planned place of birth
2000     Centre for Clinical Effectiveness (CCE) The bleeding patterns which can occur with long term hormone replacement therapy (HRT) and how they correlate with endometrial pathology
2005     NIHR Health Technology Assessment programme The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
2005     NIHR Health Technology Assessment programme The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
2023     Agency for Care Effectiveness (ACE) The CADScor System as a rule-out test for symptomatic patients suspected to have coronary artery disease
2015     NIHR Health Technology Assessment programme The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis
2016     NIHR Health Services and Delivery Research programme The care of dying people in nursing homes and intensive care units: a qualitative mixed-methods study
2005     NIHR Health Technology Assessment programme The causes and effects of socio-demographic exclusions from clinical trials
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) The challenges of early assessment: leukotriene receptor antagonists
2019     NIHR Health Services and Delivery Research programme The changing general practitioner workforce: the development of policies and strategies aimed at retaining experienced GPs and those taking a career break in direct patient care (ReGROUP)
2014     NIHR Health Technology Assessment programme The clinical and cost effectiveness of ablative therapies in the management of liver metastases: systematic review and economic modelling study
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost effectiveness of biventricular pacing for patients with severe heart failure: addendum report ; January 2005 [updated January 2006]
2014     NIHR Health Technology Assessment programme The clinical and cost effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost effectiveness of counselling interventions for heavy alcohol drinkers to reduce domestic violence
2005     NIHR Health Technology Assessment programme The clinical and cost effectiveness of drotecogin alfa-activated (Xigris) for the treatment of severe sepsis or septic shock in adults - NICE Technology Assessment Report
2008     Quality Improvement Scotland (NHS QIS ) The clinical and cost effectiveness of hyperbaric oxygen therapy (HBOT)
2011     Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of long-term ventricular assist devices (VADs) as a bridge-to-transplant in adults
2007     Quality Improvement Scotland (NHS QIS ) The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA)
2008     Quality Improvement Scotland (NHS QIS ) The clinical and cost effectiveness of surgical insertion of grommets for otitis media with effusion (glue ear) in children
2010     NIHR Health Technology Assessment programme The clinical and cost effectiveness of testing for cytochrome P450 polymorphisms in patients treated with antipsychotics: a systematic review and economic evaluation
2011     Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of the use of brachytherapy to treat breast cancer
2011     Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of the use of brachytherapy to treat localised prostate cancer
2007     Quality Improvement Scotland (NHS QIS ) The clinical and cost effectiveness of thromboelastography/thromboelastometry
2004     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
2008     Institute of Applied Health Sciences (IAHS) The clinical and cost-effectiveness of computed tomography as an alternative to angiography in investigation of coronary artery disease
2013     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of different treatment pathways for neuropathic pain (NP)
2006     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost-effectiveness of immunoprophylaxis against respiratory syncytial virus with palivizumab in children
2005     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review
2008     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost-effectiveness of intensive versus standard lipid lowering with statins in the prevention of cardiovascular events amongst patients with acute coronary syndromes: a systematic review
2005     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171)
2006     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation
2003     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation
2003     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors
2012     Scottish Health Technologies Group (SHTG) The clinical and cost-effectiveness of radiofrequency ablation for lung cancer
2013     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of rifaximin for maintaining remission from episodes of hepatic encephalopathy
2000     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of trastuzumab and vinorelbine for breast cancer
2023     Scottish Health Technologies Group (SHTG) The clinical effectiveness and cost effectiveness of a digital type 2 diabetes remission programme
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical effectiveness and cost effectiveness of antibiotic regimens for pelvic inflammatory disease
2005     NIHR Health Technology Assessment programme The clinical effectiveness and cost effectiveness of electroconvulsive therapy (ECT)
2005     NIHR Health Technology Assessment programme The clinical effectiveness and cost effectiveness of immuno-suppressive regimens for renal transplantation
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis
2001     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical effectiveness and cost utility of photodynamic therapy for age-related macular degeneration
2016     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model
2008     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation
2013     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No. 150 and part review of technology appraisal No. 118): a systematic review and economic model
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2006     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation
2006     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review
2016     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
2012     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
2012     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model
2006     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy: a systematic review
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of open mesh repairs in adults presenting with a clinically diagnosed primary unilateral inguinal hernia who are operated in an elective setting: systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review
2001     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2012     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
2001     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review
2010     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche
2003     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of routine dental checks: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation
2008     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and stabismus in children up to the ages of 4-5 years: a systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation
2012     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of telephone triage for managing same-day consultation requests in general practice: a cluster randomised controlled trial comparing general practitioner-led and nurse-led management systems with usual care (the ESTEEM trial)
2010     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome: a systematic review
2023     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The clinical effectiveness of denosumab (Prolia) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis
2008     NIHR Health Technology Assessment programme The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review
2017     NIHR Health Technology Assessment programme The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations
2017     NIHR Health Technology Assessment programme The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations